AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Once you’ve gained a solid understanding of Linux and mastered the various commands available, your next big win comes in the form of shell functions. Code wrapped in a function can be reused by your ...

Learn how Claude's ability to monitor its internal states could transform AI safety and provide insights into human brain ...

The possibility that our entire universe merely exists inside a computer simulation is more than an idle science fiction ...

By any measure, there is an enormous number of programming languages. Some lists contain hundreds, while the Historical ...

A new physics study challenges the simulation hypothesis, arguing that the universe contains realities that can likely never ...

During the early 2000s, the word “gay” floated through casual speech like punctuation: a throwaway adjective that collapsed ...

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the ...

Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

Previous Community Perspectives have described threats posed by Artificial Intelligence (AI) and its convergence with the rapidly expanding technological ecosystem — especially nanotechnology, ...